Literature DB >> 20738877

Correction: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus.

Juliana Levy1, Roberta A Cobas, Marília B Gomes.   

Abstract

Entities:  

Year:  2010        PMID: 20738877      PMCID: PMC2933610          DOI: 10.1186/1758-5996-2-57

Source DB:  PubMed          Journal:  Diabetol Metab Syndr        ISSN: 1758-5996            Impact factor:   3.320


× No keyword cloud information.

Correction

Since publication of our article [1], we have noticed that amendments to the second sentence of the "Study Design" section are required as this should read as follows: "Approved by the local ethics committee, patient enrolment was restricted to the following patients: those aged 18 years and greater and taking immediate release metformin alone or in combination with other oral agents, those excluded had symptoms of poor diabetes control, were pregnant, had serum creatinine levels >1.3 mg/dL (female) or 1.4 mg/dL (male), nephropathy, evidence of hepatic disease or history of alcohol abuse." We apologize for any inconvenience or confusion that this may have caused.
  1 in total

1.  Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus.

Authors:  Juliana Levy; Roberta A Cobas; Marília B Gomes
Journal:  Diabetol Metab Syndr       Date:  2010-03-18       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.